Loading clinical trials...
Loading clinical trials...
Metronomic Chemotherapy With Anti-angiogenic Effect as Maintenance Treatment for Metastatic Colorectal Carcinoma Following Response to FOLFIRI+Bevacizumab: Clinical and Laboratory Studies
Conditions
Interventions
CAPECITABINE, CELECOXIB and METHOTREXATE
Locations
1
Israel
HaEmek Medical Center
Afula, Israel
Start Date
September 1, 2012
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2014
Last Updated
July 8, 2015
NCT05759728
NCT07328087
NCT07213570
NCT06889610
NCT05200442
NCT05057052
Lead Sponsor
HaEmek Medical Center, Israel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions